Impact of co‐morbidities on resource use and adherence to guidelines among commercially insured adults with new visits for back pain

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2753|23|6|1218-1226

ISSN： 1356-1294

Source： JOURNAL OF EVALUATION IN CLINICAL PRACTICE (ELECTRONIC), Vol.23, Iss.6, 2017-12, pp. : 1218-1226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adherence to dornase alfa treatment among commercially insured patients with cystic fibrosis

By Nasr Samya Z.  

Journal of Medical Economics, Vol. 16, Iss. 6, 2013-06 ,pp. : 801-808

Informa Healthcare

Access to resources Recommend Favorite

Economic burden and co-morbidities of atrial fibrillation in a privately insured population

By Wu Eric Q.   Birnbaum Howard G.   Mareva Milena   Tuttle Edward   Castor Adam R.   Jackman Warren   Ruskin Jeremy  

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1693-1699

Informa Healthcare

Access to resources Recommend Favorite

Insomnia-related comorbidities and economic costs among a commercially insured population in the United States

By Pollack Michael   Seal Brian   Joish Vijay N.   Cziraky Mark J.  

Current Medical Research and Opinion, Vol. 25, Iss. 8, 2009-08 ,pp. : 1901-1911

Informa Healthcare

Access to resources Recommend Favorite

Average daily dose, medication adherence, and healthcare costs among commercially-insured patients with fibromyalgia treated with duloxetine

By Wu N   Chen S   Boulanger L   Rao P   Zhao Y  

Current Medical Research and Opinion, Vol. 27, Iss. 6, 2011-06 ,pp. : 1131-1139

Informa Healthcare

Access to resources Recommend Favorite

The Burden of Undiagnosed Opioid Abuse Among Commercially Insured Individuals

By  

PAIN MEDICINE, Vol. 16, Iss. 7, 2015-07 ,pp. : 1325-1332

John Wiley & Sons Inc

Access to resources Recommend Favorite